(Q35698278)

9 August 2017

1 reference

title

Solubilizing excipients in oral and injectable formulations (English)

1 reference

9 August 2017

Robert G Strickley

1

1 reference

9 August 2017

publication date

1 February 2004

1 reference

9 August 2017

published in

Pharmaceutical Research

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

201-230

1 reference

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

9 August 2017

cites work

1 reference

12 December 2020

Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type

1 reference

12 December 2020

Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin

1 reference

12 December 2020

Solubility principles and practices for parenteral drug dosage form development

1 reference

12 December 2020

Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers

1 reference

12 December 2020

Review of excipients and pH's for parenteral products used in the United States.

1 reference

12 December 2020

Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injection

1 reference

12 December 2020

Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems

1 reference

12 December 2020

Lysis of human red blood cells 1: Effect of contact time on water induced hemolysis

1 reference

12 December 2020

A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro

1 reference

12 December 2020

Parenteral formulations of small molecules therapeutics marketed in the United States (1999). Part III.

1 reference

12 December 2020

Excipient-drug interactions in parenteral formulations

1 reference

12 December 2020

Lysis of human red blood cells in the presence of various cosolvents. II. The effect of differing NaCl concentrations

1 reference

12 December 2020

Enteric coated HPMC capsules designed to achieve intestinal targeting

1 reference

12 December 2020

Role of the development scientist in compound lead selection and optimization

1 reference

12 December 2020

Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule

1 reference

12 December 2020

The biocompatibility of parenteral vehicles--in vitro/in vivo screening comparison and the effect of excipients on hemolysis

1 reference

12 December 2020

Effect of organic cosolvent-induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepam.

1 reference

12 December 2020

Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats

1 reference

12 December 2020

Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation

1 reference

12 December 2020

Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension

1 reference

12 December 2020

Parenteral formulations of small molecules therapeutics marketed in the United States (1999)--Part I.

1 reference

12 December 2020

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

1 reference

12 December 2020

Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

1 reference

12 December 2020

Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether.

1 reference

12 December 2020

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

1 reference

12 December 2020

Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers

1 reference

12 December 2020

Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data

1 reference

12 December 2020

Stable supersaturated aqueous solutions of silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin via chemical conversion in the presence of a chemically modified beta-cyclodextrin

1 reference

12 December 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

12 December 2020

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

1 reference

12 December 2020

Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions

1 reference

12 December 2020

An intravenous formulation decision tree for discovery compound formulation development

1 reference

12 December 2020

Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches

1 reference

12 December 2020

Lysis of human red blood cells in the presence of various cosolvents

1 reference

12 December 2020

Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts

1 reference

12 December 2020

Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains

1 reference

12 December 2020

Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.

1 reference

12 December 2020

Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions

1 reference

12 December 2020

Microemulsions: an overview and pharmaceutical applications

1 reference

12 December 2020

General pharmaceutics--the new physical pharmacy

1 reference

12 December 2020

Compendium of excipients for parenteral formulations.

1 reference

12 December 2020

Current perspectives on pain upon injection of drugs

1 reference

12 December 2020

Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats

1 reference

12 December 2020

Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.

1 reference

12 December 2020

10.1023/B:PHAM.0000016235.32639.23

Identifiers

DOI

1 reference

9 August 2017

1 reference